Abstract
Charcot-Marie-Tooth (CMT) disease is a clinically and genetically heterogeneous distal symmetric polyneuropathy. Whole-exome sequencing (WES) of 40 individuals from 37 unrelated families with CMT-like peripheral neuropathy refractory to molecular diagnosis identified apparent causal mutations in ~45% (17/37) of families. Three candidate disease genes are proposed, supported by a combination of genetic and in vivo studies. Aggregate analysis of mutation data revealed a significantly increased number of rare variants across 58 neuropathy-associated genes in subjects versus controls, confirmed in a second ethnically discrete neuropathy cohort, suggesting that mutation burden potentially contributes to phenotypic variability. Neuropathy genes shown to have highly penetrant Mendelizing variants (HPMVs) and implicated by burden in families were shown to interact genetically in a zebrafish assay exacerbating the phenotype established by the suppression of single genes. Our findings suggest that the combinatorial effect of rare variants contributes to disease burden and variable expressivity.
Original language | English (US) |
---|---|
Pages (from-to) | 1169-1183 |
Number of pages | 15 |
Journal | Cell reports |
Volume | 12 |
Issue number | 7 |
DOIs | |
State | Published - Aug 18 2015 |
Funding
This work was supported in part by US National Institute of Neurological Disorders and Stroke (NINDS) grant R01NS058529 to J.R.L.; US National Human Genome Research Institute (NHGRI) grant National Heart, Lung, and Blood Institute (NHLBI) grant U54HG006542 to the Baylor-Hopkins Center for Mendelian Genomics and US National Human Genome Research Institute (NHGRI) grant U54HG003273 to R.A.G.; by seed funding from the Center for Human Disease Modeling, Duke University and by P50 MH094268 to N.K. A.A. is supported by a grant from the Muscular Dystrophy Association (MDA294479). W.W. is supported by the Career Development Award K23NS078056 from NINDS. T.H. is supported by the T32 GM07526-37 Medical Genetics Research Fellowship Program. L.B.G. was supported by the NIH Cellular and Molecular Biology Training Grant (GM007315), the NIH Medical Scientist Training Grant (GM07863), and an NIH F30 NRSA (NS092238). M.S. is supported by grants from MDA, CMTA, and NINDS/NCATS (U54NS065712) and from NINDS (R01NS075764).
ASJC Scopus subject areas
- General Biochemistry, Genetics and Molecular Biology